Rephine Appoints Claire Meadowcroft as Chief Growth Officer to Lead Next Phase of Global Expansion
Rephine, a leading provider of GxP compliance services, audits, consulting, and digital solutions to the pharmaceutical, biotech, and medical device industries, today announced the appointment of Claire Meadowcroft as Chief Growth Officer (CGO). Claire, who joined Rephine on 1 September, is leading the company’s commercial growth strategy as the company accelerates its global expansion and deepens its partnerships across life sciences. With over 20 years of experience in healthcare, including 15
Read disclosure →